As to anti-angiogenesis in cancer therapy, Notch signaling functions in the physiologic response to loss of VEGF signaling, and thus participates in tumor adaptation to VEGF inhibitors in human NGP neuroblastoma cells [73]. This evidence concerns the gene VEGFA and neuroblastoma.